AstraZeneca Forecasts Increased Profit and Sales Driven by Cancer Drug Success

AstraZeneca, the renowned biopharmaceutical company, has announced optimistic financial projections, attributing its anticipated growth to a surge in sales from its cancer treatment portfolio. The company’s latest guidance reflects an expected rise in profit as well as sales, bolstered significantly by its innovative oncology drugs.

Continue reading